CIBC Asset Management
TAK icon

CIBC Asset Management’s Takeda Pharmaceutical TAK Stock Holding History

CIBC Asset Management’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-333,617
Closed -$5.46M – 1599
2021
Q3 		$5.46M Sell
333,617
-242,934
-42% -$4.08M 0.02% 335
2021
Q2 		$9.7M Sell
576,551
-13,523
-2% -$230K 0.04% 241
2021
Q1 		$10.8M Buy
590,074
+83,370
+16% +$1.5M 0.05% 211
2020
Q4 		$9.22M Sell
506,704
-459,463
-48% -$8.06M 0.04% 223
2020
Q3 		$17.2M Sell
966,167
-140,475
-13% -$2.56M 0.09% 136
2020
Q2 		$19.8M Sell
1,106,642
-125,570
-10% -$2.25M 0.12% 116
2020
Q1 		$18.7M Buy
1,232,212
+59,125
+5% +$1.07M 0.13% 106
2019
Q4 		$23.1M Sell
1,173,087
-60,857
-5% -$1.16M 0.13% 84
2019
Q3 		$21.2M Sell
1,233,944
-39,267
-3% -$679K 0.12% 89
2019
Q2 		$22.5M Buy
1,273,211
+551,472
+76% +$10M 0.13% 80
2019
Q1 		$14.7M Buy
+721,739
New +$14.5M 0.09% 106

Other funds holding TAK

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BCP
BSN Capital Partners London, United Kingdom $3.93B AUM 13.09% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CIBC Asset Management's TAK Position: Q4 2021 in Review

CIBC Asset Management sold out of Takeda Pharmaceutical (TAK) in Q4 2021, closing a stake of 333,617 shares — an estimated $5.46M sold.

CIBC Asset Management first reported a position in TAK in Q1 2019 and held it in 11 quarters. The position peaked at $23.1M in Q4 2019. 298 funds tracked by Wall St. Rank hold TAK as of Q4 2021.

  • CIBC Asset Management reported no remaining Takeda Pharmaceutical position as of Q4 2021 after selling out during the quarter.
  • CIBC Asset Management sold 333,617 Takeda Pharmaceutical shares in Q4 2021, an estimated $5.46M.
  • CIBC Asset Management first reported a position in Takeda Pharmaceutical in Q1 2019 and held it in 11 quarters.
  • CIBC Asset Management's Takeda Pharmaceutical position peaked at $23.1M in Q4 2019.
  • 298 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q4 2021.

Based on CIBC Asset Management's 13F filing for Q4 2021, filed 8 Feb 2022.